Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanesa Pytel

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Scientific Reports|April 3, 2023
A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stressXavier Morató, Marta Marquié, Juan Pablo Tartari, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Connecting genomic and proteomic signatures of amyloid burden in the brainRaquel Puerta, Itziar de Rojas, Pablo García-González, et al.
Research Square|July 16, 2024
Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel diseaseStephanie Debette, Ilana Caro, Daniel Western, et al.
Functional & Integrative Genomics|March 26, 2025
Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCORaquel Puerta, Itziar de Rojas, Pablo García-González, et al.
Nature Aging|November 20, 2025
Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel diseaseIlana Caro, Daniel Western, Shinichi Namba, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Scientific Reports|April 3, 2023
A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stressXavier Morató, Marta Marquié, Juan Pablo Tartari, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Connecting genomic and proteomic signatures of amyloid burden in the brainRaquel Puerta, Itziar de Rojas, Pablo García-González, et al.
Research Square|July 16, 2024
Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel diseaseStephanie Debette, Ilana Caro, Daniel Western, et al.
Functional & Integrative Genomics|March 26, 2025
Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCORaquel Puerta, Itziar de Rojas, Pablo García-González, et al.
Nature Aging|November 20, 2025
Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel diseaseIlana Caro, Daniel Western, Shinichi Namba, et al.
Pageof 7